白念珠菌生物膜相关基因对耐药性的影响

摘要/Abstract

中图分类号:

R379

郭晓宇, 李小静. 白念珠菌生物膜相关基因对耐药性的影响[J]. 中国真菌学杂志, 2021, 16(6): 428-432.

[1] LOHSE M B, GULATI M, JOHNSON A D, et al. Development and regulation of single- and multi-species Candida albicans biofilms[J]. Nat Rev Microbiol,2018,16(1):19-31.
[2] MCCALL A, EDGERTON M. Real-time approach to flow cell imaging of Candida albicans biofilm development[J]. J Fungi (Basel),2017,3(1):13.
[3] DESAI J V, MITCHELL A P.Candida albicans biofilm development and its genetic control[J]. Microbiol Spectr,2015,3(3):10.
[4] GRANGER B L. Accessibility and contribution to glucan masking of natural and genetically tagged versions of yeast wall protein 1 of Candida albicans[J]. PLoS One,2018,13(1):e0191194.
[5] 何淼,宋光泰,边专.白色念珠菌ALS基因家族在生物膜形成过程中的差异表达[J].口腔医学研究,2015,31(10):957-960.
[6] GULATI M, NOBILE C J.Candida albicans biofilms: development, regulation, and molecular mechanisms[J]. Microbes Infect,2016,18(5):310-321.
[7] DANIELS K J, SRIKANTHA T, Pujol C, et al. Role of Tec1 in the development, architecture, and integrity of sexual biofilms of Candida albicans[J]. Eukaryot Cell,2015,14(3):228-240.
[8] SU C, LU Y, LIU H.Reduced TOR signaling sustains hyphal development in Candida albicans by lowering Hog1 basal activity[J]. Mol Biol Cell,2013,24(3):385-397.
[9] XU H, SOBUE T, BERTOLINI M, et al.S. oralis activates the Efg1 filamentation pathway in C. albicans to promote cross-kingdom interactions and mucosal biofilms[J]. Virulence,2017,8(8):1602-1617.
[10] FOX E P, BUI C K, NETT J E, et al. An expanded regulatory network temporally controls Candida albicans biofilm formation[J]. Mol Microbiol,2015,96(6):1226-1239.
[11] CHEN H F, LAN C Y. Role of SFP1 in the regulation of Candida albicans biofilm formation[J]. Plos One,2015,10(6):e0129903.
[12] KAKADE P, SADHALE P, SANYAL K, et al. ZCF32, a fungus specific Zn(II)2 Cys6 transcription factor, is a repressor of the biofilm development in the human pathogen Candida albicans[J]. Sci Rep,2016,6(1):31124.
[13] ROCHA C R, SCHRÖPPEL K, HARCUS D, et al.Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans[J]. Mol Biol Cell,2001,12(11):3631-3643.
[14] MANCUSO R, CHINNICI J, TSOU C, et al.Functions of Candida albicans cell wall glycosidases Dfg5p and Dcw1p in biofilm formation and HOG MAPK pathway[J]. PeerJ,2018,6:e5685.
[15] FREIRE F, DE BARROS P P, PEREIRA C A, et al. Photodynamic inactivation in the expression of the Candida albicans genes ALS3, HWP1, BCR1, TEC1, CPH1, and EFG1 in biofilms[J]. Lasers Med Sci,2018,33(7):1447-1454.
[16] CHILDERS D S, KADOSH D. Filament condition-specific response elements control the expression of NRG1 and UME6, key transcriptional regulators of morphology and virulence in Candida albicans[J]. PLoS One,2015,10(3):e0122775.
[17] HALBANDGE S D, JADHAV A K, JANGID P M, et al. Molecular targets of biofabricated silver nanoparticles in Candida albicans[J]. J Antibiot (Tokyo),2019,72(8):640-644.
[18] JIA W, ZHANG H, LI C, et al. The calcineruin inhibitor cyclosporine asynergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms[J]. BMC Microbiol,2016,16(1):113.
[19] 郭东东,岳慧珍,魏羽佳,等.白念珠菌生物被膜形成的遗传调控机制[J].生物工程学报,2017,33(9):1567-1581.
[20] 闻轶旸,黄欣,沈帅帅,等.基于Hog-MAPK信号通路探讨白念珠菌氟康唑耐药机制的实验研究[J].中国真菌学杂志,2015,10(6):345-351.
[21] KIM S H, IYER K R, PARDESHI L, et al. Genetic analysis of Candida auris implicates Hsp90 in morphogenesis and azole tolerance and Cdr1 in azole resistance[J]. mBio,2019,10(1):e02529-18.
[22] SANDAI D, TABANA Y M, OUWEINI A E, et al.Resistance of Candida albicans biofilms to drugs and the host immune system[J]. Jundishapur J Microbiol,2016,9(11):e37385.
[23] SHAO J, CUI Y, ZHANG M, et al.Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions[J]. Pharm Biol,2017,55(1):355-359.
[24] VORKAPIC D, PRESSLER K, SCHILD S. Multifaceted roles of extracellular DNA in bacterial physiology[J]. Curr Genet,2016,62(1):71-79.
[25] 高来强,王海英,王学红,等.白念珠菌氟康唑耐药株与敏感株SRB1、CDR1、ERG11表达比较分析[J].中国真菌学杂志,2017,12(3):148-151,155.
[26] IBRAHIM N H, MELAKE N A, SOMILY A M, et al. The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms[J]. Saudi Pharm J,2015,23(1):55-66.
[27] ZHANG J, LI L, LV Q, et al. The fungal CYP51s: Their functions, structures, related drug resistance, and inhibitors[J]. Front Microbiol,2019,10:691.
[28] ROBBINS N, UPPULURI P, NETT J, et al. Hsp90 governs dispersion and drug resistance of fungal biofilms[J]. PLoS Pathog,2011,7(9):e1002257.
[29] RYBAK J M, DICKENS C M, PARKER J E, et al. Loss of C-5 sterol desaturase activity results in increased resistance to azole and echinocandin antifungals in a clinical isolate of Candida parapsilosis[J]. Antimicrob Agents Chemother,2017,61(9):e00651-17.
[30] MUKHERJEE P K, CHANDRA J, KUHN D M, et al. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols[J]. Infect Immun,2003,71(8):4333-4340.
[31] RYBAK J M, DOORLEY L A, NISHIMOTO A T, et al. Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris[J]. Antimicrob Agents Chemother,2019,63(4):e00057-19.
[32] LIU Z, ROSSI J M, MYERS L C. Candida albicans Zn cluster transcription factors Tac1 and Znc1 are activated by farnesol to upregulate a transcriptional program including the multidrug efflux pump CDR1[J]. Antimicrob Agents Chemother,2018,62(11):e00968-18.
[33] MORSCHHÄUSER J. The genetic basis of fluconazole resistance development in Candida albicans[J]. Biochim Biophys Acta,2002,1587(2-3):240-248.
[34] WANG T, SHAO J, DA W, et al. Strong synergism of palmatine and fluconazole/itraconazole against planktonic and biofilm cells of Candida species and efflux-associated antifungal mechanism[J]. Front Microbiol,2018,9:2892.
[35] SASSE C, SCHILLIG R, DIEROLF F, et al. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans[J]. PLoS One,2017,6(9):e25623.
[36] KEAN R, RAMAGE G. Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris[J]. mSphere,2019,4(4):e00458-19.
[37] Sun J, Li Z, Chu H, et al. Candida albicans amphotericin B-tolerant persister formation is closely related to surface adhesion[J]. Mycopathologia,2016,181(1-2):41-49.
[38] 孙静.表面附着、休眠对白色念珠菌生物膜滞留菌形成的影响及滞留菌相关基因的初步筛选[D].山东大学,2015.
[39] BRANCO J, OLA M, SILVA R M, et al. Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance[J]. Clin Microbiol Infect,2017,23(8):575.e1-575.e8.
[40] WUYTS J, VAN DIJCK P, HOLTAPPELS M. Fungal persister cells: The basis for recalcitrant infections [J]? PLoS Pathog,2018,14(10):e1007301.
[41] LI S, SHI H, CHANG W, et al. Eudesmane sesquiterpenes from Chinese liverwort are substrates of Cdrs and display antifungal activity by targeting Erg6 and Erg11 of Candida albicans[J]. Bioorg Med Chem, 2017, 25(20): 5764-5771.
[42] FENG W, YANG J, XI Z, et al. Mutations and/or overexpressions of ERG4 and ERG11 genes in clinical azolesresistant isolates of Candida albicans[J]. Microb Drug Resist, 2017, 23(5): 563-570.
[43] 王小燕,杨堃,黄云超,等.真菌密度感应分子Farnesol在表皮葡萄球菌和白假丝酵母菌混合生物膜形成中的作用[J].西安交通大学学报(医学版),2015,36(2):153-158.
[44] RAJENDRAN R, MOWAT E, JONES B, et al. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms[J]. Int J Antimicrob Agents,2015,46(3):342-345.
[45] 郭彦伟,王凌峰,孟昭彦,等.真菌生物膜耐药机制与防治研究进展[J].中外医疗,2014,33(27):197-198.

白念珠菌生物膜相关基因对耐药性的影响

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张伟铮, 肖英伦, 彭湘明, 李松, 张轩, 陈茶. 肉桂醛对阿萨希毛孢子菌临床分离株的生长及其生物膜形成的影响[J]. 中国真菌学杂志, 2021, 16(5): 296-302.
[2]	李彩云, 柯婷婷, 李刚, 赵梅, 王文. 不同产膜能力的念珠菌对妊娠期阴道炎患者Toll样受体通路及妊娠结局的影响[J]. 中国真菌学杂志, 2021, 16(5): 330-334.
[3]	张欠欠, 罗传玉, 陈嘉琪, 封小川. 白念珠菌感染现状及抗真菌药物研究进展[J]. 中国真菌学杂志, 2021, 16(5): 356-360.
[4]	孟玲宁, 刘锦燕, 项明洁, 沈瀚. 白念珠菌TFP1基因与钙调神经磷酸酶通路的相关性分析[J]. 中国真菌学杂志, 2021, 16(4): 217-221.
[5]	王莉, 王华, 周洁, 翟晓翔. 他克莫司与常用抗真菌药体外协同抗白念珠菌作用的初探[J]. 中国真菌学杂志, 2021, 16(4): 257-261.
[6]	郝小康, 王宇鹤, 徐世林, 李楠. 土槿乙酸与氟康唑联合抗白念珠菌作用的研究[J]. 中国真菌学杂志, 2021, 16(4): 262-265.
[7]	谢韵, 张丽娟, 帕丽达·阿布利孜. 分离自1例慢性阻塞性肺疾病患者的Aspergillus lentulus在蜡螟模型上的毒力初探[J]. 中国真菌学杂志, 2021, 16(3): 155-160.
[8]	李倩倩, 邵菁, 吴大强, 汪天明, 汪长中. 影响念珠菌混合生物膜形成因素的研究进展[J]. 中国真菌学杂志, 2021, 16(3): 202-206.
[9]	熊延靖, 厉荣玉, 吴艳红. 大蒜素对白念珠菌形态转换的影响研究[J]. 中国真菌学杂志, 2021, 16(1): 14-18.
[10]	华可心, 于淑颖, 徐英春. 白念珠菌生物被膜的研究进展[J]. 中国真菌学杂志, 2021, 16(1): 56-59.
[11]	刘丹, 邢丽枝, 杨心茹, 罗伟, 何荣霞. 唑类药物治疗外阴阴道假丝酵母菌病研究进展[J]. 中国真菌学杂志, 2020, 15(5): 318-320.
[12]	马玉帛, 张逸, 黄晨, 王晓雯, 李若瑜. 自然杀伤细胞在真菌感染免疫的研究进展[J]. 中国真菌学杂志, 2020, 15(3): 175-178.
[13]	邱熙然, 陈思敏, 侯炜彤, 张玉, 郭诗雨, 姜远英, 安毛毛. 白念珠菌侵袭宿主毒力因子研究进展[J]. 中国真菌学杂志, 2020, 15(3): 183-188.
[14]	张静云, 彭靖雯, 王琼, 高盈, 陈万鑫, 沈永年, Li Dong-mei, 佘晓东, 刘维达. 表皮生长因子受体在阴道念珠菌病发病过程中的作用初探[J]. 中国真菌学杂志, 2020, 15(2): 65-71.
[15]	刘光荣, 翟春涛, 金敏蓉, 李成亮. 天然抗菌剂对5种致病菌的抑制作用研究[J]. 中国真菌学杂志, 2020, 15(2): 88-92.